Sometimes you just need a quick reminder why you moved to Linux.

Nearly 80 percent of organizations now use AI in at least one core business process, according to McKinsey, yet widespread adoption has surfaced a persistent problem: a deep shortage of professionals ...

Trump's war goals included putting an end to Iran's nuclear program, destroying its military capabilities and creating regime ...

Managing multiple Claude Code projects doesn't have to be chaotic. My iTerm2 setup dramatically reduces friction in my daily AI-assisted coding workflows - here's how.

MADISON, Wis. (WQOW) – A bill creating a state matching program to help homeless veterans after Klein Hall in Chippewa Falls closed is now law in Wisconsin. The new law adds an additional $25 per day ...

Gen. Stephen Whiting noted the number of personnel at Redstone is expected to grow to nearly 200 by the end of 2026. (Staff Sgt. Kirsten Brandes/U.S. Space Force) U.S. Space Command is operating a ...

LOUISVILLE, Ky. — Kentucky's governor just signed a bill that makes it easier for homeowners to create a safe room. Gov. Andy Beshear signed Senate Bill 11 into law on Monday. The measure creates a ...

FRANKFORT, Ky. (WSMV) - Kentucky Gov. Andy Beshear signed legislation on Monday creating a statewide rebate program for Kentucky residents to have severe weather safe rooms. “Kentucky has faced 15 ...

The command line is hot again. For some people, command lines were never not hot, of course, but it’s becoming more common now in the age of AI. Google launched a Gemini command-line tool last year, ...

Jean-Pierre Sommadossi, Founder, Chairman, CEO & President, reported substantial clinical progress, highlighting advancement in the global Phase III program evaluating bemnifosbuvir and ruzasvir for ...

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...